Published in Gut on February 01, 1986
Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction. Eur J Clin Pharmacol (2008) 2.36
Sedation for fibreoptic bronchoscopy. Thorax (1989) 1.35
Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients. Br J Clin Pharmacol (2004) 0.94
Intestinal first pass metabolism of midazolam in liver cirrhosis --effect of grapefruit juice. Br J Clin Pharmacol (2002) 0.85
Reduced duodenal cytochrome P450 3A protein expression and catalytic activity in patients with cirrhosis. Clin Pharmacol Ther (2009) 0.84
Correlation between midazolam and lignocaine pharmacokinetics and MEGX formation in healthy volunteers. Br J Clin Pharmacol (2002) 0.83
Potential drug-drug interactions and adverse drug reactions in patients with liver cirrhosis. Eur J Clin Pharmacol (2011) 0.81
Update of endoscopy in liver disease: more than just treating varices. World J Gastroenterol (2012) 0.81
CYP3A activity in severe liver cirrhosis correlates with Child-Pugh and model for end-stage liver disease (MELD) scores. Br J Clin Pharmacol (2014) 0.81
Dose adjustment in patients with liver cirrhosis: impact on adverse drug reactions and hospitalizations. Eur J Clin Pharmacol (2013) 0.80
Effect of hepatic function on the EC50 of midazolam and the BIS50 at the time of loss of consciousness. J Zhejiang Univ Sci B (2014) 0.80
The pharmacokinetics of midazolam following orthotopic liver transplantation. Br J Clin Pharmacol (1989) 0.77
Changes in cytochrome P450s-mediated drug clearance in patients with hepatocellular carcinoma in vitro and in vivo: a bottom-up approach. Oncotarget (2016) 0.76
Safety and effectiveness of low-dose propofol sedation during and after esophagogastroduodenoscopy in child A and B cirrhotic patients. Dig Dis Sci (2012) 0.75
Benzodiazepine-associated hepatic encephalopathy significantly increased healthcare utilization and medical costs of Chinese cirrhotic patients: 7-year experience. Dig Dis Sci (2014) 0.75
Commentary: a physiological approach to hepatic drug clearance. Clin Pharmacol Ther (1975) 7.96
The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function. Clin Sci (1961) 6.71
The effects of age and liver disease on the disposition and elimination of diazepam in adult man. J Clin Invest (1975) 4.65
Psychomotor function and psychoactive drugs. Br J Clin Pharmacol (1980) 3.57
Midazolam kinetics. Clin Pharmacol Ther (1981) 2.88
The pharmacokinetics of midazolam in man. Eur J Clin Pharmacol (1981) 2.45
Increased long-term survival in variceal haemorrhage using injection sclerotherapy. Results of a controlled trial. Lancet (1982) 2.30
Clearance concepts in pharmacokinetics. J Pharmacokinet Biopharm (1973) 2.16
Automated gas chromatography for studies of midazolam pharmacokinetics. Anesthesiology (1981) 1.78
Excretion and metabolism of 14C-midazolam in humans following oral dosing. Arzneimittelforschung (1981) 1.71
Normal disposition of oxazepam in acute viral hepatitis and cirrhosis. Ann Intern Med (1976) 1.68
Hepatic disease and drug pharmacokinetics. Clin Pharmacokinet (1981) 1.42
Comparison of midazolam and diazepam in doses of comparable potency during gastroscopy. Br J Anaesth (1983) 1.40
Effects of aging and liver disease on disposition of lorazepam. Clin Pharmacol Ther (1978) 1.39
Effects of chlorpromazine in patients with hepatic disease. Br Med J (1969) 1.31
Effects of cimetidine on carbamazepine auto- and hetero-induction in man. Br J Clin Pharmacol (1984) 1.19
Intravenous administration of diazepam in patients with chronic liver disease. Gut (1976) 1.08
Midazolam, a new more potent benzodiazepine, compared with diazepam: a randomized, double-blind study of preendoscopic sedatives. Gastrointest Endosc (1983) 1.02
Accumulation of midazolam in patients receiving mechanical ventilation. Br Med J (Clin Res Ed) (1984) 0.94
Plasma concentrations and central nervous system effects of the new hypnotic agent zopiclone in patients with chronic liver disease. Br J Clin Pharmacol (1983) 0.93
Accumulation of midazolam after repeated dosage in patients receiving mechanical ventilation in an intensive care unit. Br Med J (Clin Res Ed) (1984) 0.92
The disposition and effects of sedatives and analgesics in liver disease. Annu Rev Med (1978) 0.90
Clinical effects and metabolism of diazepam in patients with chronic liver disease. Clin Sci (Lond) (1982) 0.84
Drug administration in hepatic disease. N Engl J Med (1983) 0.83
Early identification of refractory epilepsy. N Engl J Med (2000) 12.43
Cancer statistics, 2000. CA Cancer J Clin (2000) 12.32
Cancer statistics, 2001. CA Cancer J Clin (2001) 11.73
Cancer statistics, 1999. CA Cancer J Clin (1999) 9.18
Explaining differences in English hospital death rates using routinely collected data. BMJ (1999) 8.27
Cancer statistics, 1998. CA Cancer J Clin (1998) 6.26
Comparison of UK paediatric cardiac surgical performance by analysis of routinely collected data 1984-96: was Bristol an outlier? Lancet (2001) 5.26
Local complications of ulcerative colitis: stricture, pseudopolyposis, and carcinoma of colon and rectum. Br Med J (1966) 4.27
Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee. Clin Cancer Res (1999) 3.24
The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. Immunity (2000) 2.93
The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB. Proc Natl Acad Sci U S A (1993) 2.90
The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada. Osteoporos Int (2001) 2.32
Lamotrigine-associated rash: risk/benefit considerations in adults and children. Epilepsia (1999) 2.29
Early course of ulcerative colitis. Gut (1966) 2.26
The BZLF1 protein of EBV has a coiled coil dimerisation domain without a heptad leucine repeat but with homology to the C/EBP leucine zipper. Oncogene (1991) 2.25
Epilepsy after the first drug fails: substitution or add-on? Seizure (2000) 2.19
US adults' fruit and vegetable intakes, 1989 to 1991: a revised baseline for the Healthy People 2000 objective. Am J Public Health (1995) 2.17
The retinoblastoma protein binds E2F residues required for activation in vivo and TBP binding in vitro. Nucleic Acids Res (1993) 2.17
Fruit and vegetable intakes of children and adolescents in the United States. Arch Pediatr Adolesc Med (1996) 2.15
New antiepileptic drugs. N Engl J Med (1996) 2.04
A radiation hybrid map of mouse genes. Nat Genet (2001) 2.03
Systems and strategies for managing the drugs budget in Glasgow. BMJ (1998) 2.01
Hypoplastic left heart syndrome: effects of fetal echocardiography on birth prevalence. Lancet (1991) 1.95
Effectiveness of first antiepileptic drug. Epilepsia (2001) 1.94
Hereditary coproporphyria. Demonstration of the abnormalities in haem biosynthesis in peripheral blood. Q J Med (1977) 1.91
Dietary sources of nutrients among US children, 1989-1991. Pediatrics (1998) 1.91
Conserved motifs in Fos and Jun define a new class of activation domain. Genes Dev (1992) 1.90
Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy. Acta Neurol Scand (2003) 1.90
Incidence of fractures in a geographically defined population. J Epidemiol Community Health (1990) 1.85
Hepatocellular carcinoma in primary biliary cirrhosis: report of four cases. Gut (1979) 1.83
Dietary sources of nutrients among US adults, 1989 to 1991. J Am Diet Assoc (1998) 1.82
Differential induction of antipyrine metabolism by rifampicin. Eur J Clin Pharmacol (1981) 1.81
The death domain kinase RIP is essential for TRAIL (Apo2L)-induced activation of IkappaB kinase and c-Jun N-terminal kinase. Mol Cell Biol (2000) 1.80
Rifampicin and vitamin D metabolism. Clin Pharmacol Ther (1980) 1.78
Carbamazepine substitution in severe partial epilepsy: implication of autoinduction of metabolism. Postgrad Med J (1985) 1.77
Long-term prognosis of ulcerative colitis. Br Med J (1966) 1.77
Controlled trial of haem arginate in acute hepatic porphyria. Lancet (1989) 1.75
Mixed function oxidase activity in microsomal fractions of human liver biopsy specimens [proceedings]. Br J Clin Pharmacol (1978) 1.75
Allergen and dust exposure as determinants of work-related symptoms and sensitization in a cohort of flour-exposed workers; a case-control analysis. Ann Occup Hyg (2001) 1.73
Multiple myeloma and the anion gap. N Engl J Med (1975) 1.72
Monooxygenase activity of human liver in microsomal fractions of needle biopsy specimens. Br J Clin Pharmacol (1980) 1.69
Primary biliary cirrhosis: an increased incidence of extrahepatic malignancies? J Clin Pathol (1982) 1.69
Lung cancer after radiation therapy for breast cancer. Cancer (1993) 1.68
Increased risk of lung cancer after breast cancer radiation therapy in cigarette smokers. Cancer (1994) 1.67
Extracorporeal shock wave lithotripsy: the first 50 patients treated in Britain. Br Med J (Clin Res Ed) (1985) 1.66
Epilepsy in elderly people. Lancet (2000) 1.64
In vitro DNA binding activity of Fos/Jun and BZLF1 but not C/EBP is affected by redox changes. Oncogene (1991) 1.63
The outcome of the first 165 orthotopic liver transplants in Scotland. Scott Med J (1999) 1.63
A new anti-p53 monoclonal antibody, previously reported to be directed against the large T antigen of simian virus 40. Oncogene (1987) 1.62
Hepatitis Bs antibody in alcoholic cirrhosis. J Clin Pathol (1979) 1.61
Rationale, design and methods of the HEALTHY study physical education intervention component. Int J Obes (Lond) (2009) 1.61
Factors affecting the incidence of deep wound infection after hip fracture surgery. J Bone Joint Surg Br (2012) 1.61
Inhaled fentanyl as a method of analgesia. Anaesthesia (1990) 1.60
Managing seizures in the casualty department. BMJ (1990) 1.58
Dietary risk factors for the incidence and recurrence of colorectal adenomatous polyps. A case-control study. Ann Intern Med (1993) 1.58
Incidence of sulphasalazine-induced male infertility. Gut (1981) 1.58
Psychopathology in people with epilepsy and intellectual disability; an investigation of potential explanatory variables. J Neurol Neurosurg Psychiatry (2003) 1.53
Diagnosis of inflammatory bowel disease: an international multicentre scoring system. Br Med J (Clin Res Ed) (1982) 1.53
The early course and prognosis of ulcerative colitis. Proc R Soc Med (1965) 1.52
Effect of isoniazid on vitamin D metabolism and hepatic monooxygenase activity. Clin Pharmacol Ther (1981) 1.52
Strategies for nevirapine initiation in HIV-infected children taking pediatric fixed-dose combination "baby pills" in Zambia: a randomized controlled trial. Clin Infect Dis (2010) 1.52
Verbal autopsy can consistently measure AIDS mortality: a validation study in Tanzania and Zimbabwe. J Epidemiol Community Health (2009) 1.51
New antiepileptic drugs. The drugs are not all the same. BMJ (1997) 1.51
Endoscopic transmission of hepatitis B virus. Gut (1983) 1.50
Strong constraints on the rare decays B(s)(0) → μ+ μ- and B0 → μ+ μ-. Phys Rev Lett (2012) 1.50
First observation of the decays B(0) → D(+)K(-)π(+)π(-) and B(-) → D(0)K(-)π(+)π(-). Phys Rev Lett (2012) 1.50
A familial neuronal disease presenting as intestinal pseudoobstruction. Gastroenterology (1978) 1.50
Does the cause of localisation-related epilepsy influence the response to antiepileptic drug treatment? Epilepsia (2001) 1.48
Which electroencephalography (EEG) for epilepsy? The relative usefulness of different EEG protocols in patients with possible epilepsy. J Neurol Neurosurg Psychiatry (2006) 1.48
Idiopathic chronic ulcerative enteritis. Report of five cases and review of the literature. Q J Med (1980) 1.48
Intraperitoneal perforation of the colon in ulcerative colitis. Proc R Soc Med (1965) 1.48
Neuropsychological effects of epilepsy and antiepileptic drugs. Lancet (2001) 1.48
The CBP co-activator stimulates E2F1/DP1 activity. Nucleic Acids Res (1996) 1.47
Evidence for an enzymatic defect in the 4-hydroxylation of debrisoquine by human liver. Br J Clin Pharmacol (1981) 1.47
An internally-standardized assay for amphotericin B in tissues and plasma. J Chromatogr (1983) 1.46
Histocompatibility antigens in active chronic hepatitis and primary biliary cirrhosis. Br Med J (1974) 1.45
Accuracy of a portable interpretive ECG machine in diagnosis of acute evolving myocardial infarction. Aust N Z J Med (1992) 1.44
c-Fos-induced activation of a TATA-box-containing promoter involves direct contact with TATA-box-binding protein. Mol Cell Biol (1994) 1.42
Determination of the X(3872) meson quantum numbers. Phys Rev Lett (2013) 1.42
Genetic testing for cancer risk: how to reconcile the conflicts. JAMA (1998) 1.42
Differences in histology between first and second primary lung cancer. Cancer Epidemiol Biomarkers Prev (1993) 1.41
Imaging with pentavalent [99mTc]DMSA in patients with medullary cancer of the thyroid. J Nucl Med (1988) 1.41
The effect of verapamil on the pharmacokinetics of adriamycin. Cancer Chemother Pharmacol (1986) 1.41
The fragile X syndrome. Aust Fam Physician (1998) 1.40
Clinical and histologic evaluation of psoriatic plaques treated with a flashlamp pulsed dye laser. J Am Acad Dermatol (1996) 1.40
A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices. Hepatology (1997) 1.39
Asbestos dressing. Br Dent J (2008) 1.39
Diagnosing refractory epilepsy: response to sequential treatment schedules. Eur J Neurol (2006) 1.36
Visual field constriction: accumulation of vigabatrin but not tiagabine in the retina. Neurology (2001) 1.36
Verapamil potentiates carbamazepine neurotoxicity: a clinically important inhibitory interaction. Lancet (1986) 1.35
Receptors mediating tachykinin-induced contractile responses in guinea-pig trachea. Br J Pharmacol (1991) 1.33
Disposition of the atrioventricular conduction tissues in the heart with isomerism of the atrial appendages: its relation to congenital complete heart block. J Am Coll Cardiol (1992) 1.32
Comparison of the in vivo and in vitro rates of formation of the three main oxidative metabolites of antipyrine in man. Br J Clin Pharmacol (1981) 1.32
CBP/p300 as a co-factor for the Microphthalmia transcription factor. Oncogene (1997) 1.31
Hemodynamic effects of oral smokeless tobacco in dogs and young adults. Prev Med (1984) 1.31
Permanent pacemaker insertion after CoreValve transcatheter aortic valve implantation: incidence and contributing factors (the UK CoreValve Collaborative). Circulation (2011) 1.30
Sudden unexplained death in epilepsy: observations from a large clinical development program. Epilepsia (1997) 1.29